Diabetic Ketoacidosis

Anda Gonciulea, M.D., Rita Rastogi Kalyani, M.D., M.H.S.

Diabetic Ketoacidosis is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

DEFINITION

A metabolic acidosis characterized by the triad of hyperglycemia (glucose >250 mg/dL), metabolic acidosis (arterial pH ≤ 7.3, serum bicarbonate ≤ 18 meq/L) and moderate ketonuria or ketonemia.
Most, but not all, patients have type 1 diabetes.
Patients with type 2 diabetes also susceptible during acute illness (especially of African American or Hispanic descent) referred to as "ketosis-prone type 2 diabetes," likely due to greater relative insulinopenia[12].

-- To view the remaining sections of this topic, please log in or purchase a subscription --

DEFINITION

A metabolic acidosis characterized by the triad of hyperglycemia (glucose >250 mg/dL), metabolic acidosis (arterial pH ≤ 7.3, serum bicarbonate ≤ 18 meq/L) and moderate ketonuria or ketonemia.
Most, but not all, patients have type 1 diabetes.
Patients with type 2 diabetes also susceptible during acute illness (especially of African American or Hispanic descent) referred to as "ketosis-prone type 2 diabetes," likely due to greater relative insulinopenia[12].

There's more to see -- the rest of this entry is available only to subscribers.